08/08/2024 3:25 PM | Eton Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024 3:16 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 3:16 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:17 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:25 PM | Eton Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024 6:15 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 6:00 AM | Eton Pharmaceuticals (Subject) HARROW, INC. (Filed by) HARROW, INC. (Filed by) HARROW, INC. (Filed by)
| Form SC 13D/A | |
04/26/2024 3:21 PM | Eton Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024 3:22 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 3:24 PM | Eton Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/22/2024 5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 3:15 PM | Eton Pharmaceuticals (Issuer) RIEDEL NORBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:16 PM | Eton Pharmaceuticals (Issuer) MAIER PAUL V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:17 PM | Eton Pharmaceuticals (Issuer) Krempa David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:18 PM | CASAMENTO CHARLES J (Reporting) Eton Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:19 PM | BRYNJELSEN SEAN (Reporting) Eton Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:19 PM | Adams Jennifer McKie (Reporting) Eton Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:21 PM | Eton Pharmaceuticals (Issuer) Gruber James R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 3:25 PM | Eton Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/04/2023 5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |